Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 6, 2007, Pages

  Callanan, Ean Y ^a   Lee, Edward W ^a   Tilan, Jason U ^a   Winaver, Joseph ^b   Haramati, Aviad ^a   Mulroney, Susan E ^a   Zukowska, Zofia ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cardiac hypertrophy; Renal blood flow; Y1 receptor; Y2 receptor

Indexed keywords

LEUCINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; NORADRENALIN; PROLINE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL MODEL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; HEART MUSCLE; KIDNEY FAILURE; MALE; MUSCLE CELL; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM EXCRETION; URINARY EXCRETION; VASOCONSTRICTION;

EID: 36549046450     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00191.2007     Document Type: Article

References (36)

1. Allen JM, Raine AE, Ledingham JG, Bloom SR. Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci (Lond) 68: 373-377, 1985.
2. Anderson FL, Port JD, Reid BB, Larrabee P, Hanson G, Bristow MR. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation 85: 46-53, 1992.
3. Engelhardt S, Bohm M, Erdmann E, Lohse MJ. Analysis of beta-adrenergic receptor mRNA levels in human ventricular biopsy specimens by quantitative polymerase chain reactions: progressive reduction of beta 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 27: 146-154, 1996.
4. Fabi F, Argiolas L, Ruvolo G, del Basso P. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane. Br J Pharmacol 124: 101-110, 1998.
5. Folkow B. Acute effects of pressure on resistance vessel geometry. Acta Physiol Scand 104: 496-498, 1978.
6. Garcia R, Diebold S. Simple, rapid, and effective method of producing aortocaval shunts in the rat. Cardiovasc Res 24: 430-432, 1990.
7. Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr, Michel MC. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 67: 33-37, 1996.
8. Grundemar L, Grundstrom N, Johansson IG, Andersson RG, Hakanson R. Suppression by neuropeptide Y of capsaicin-sensitive sensory nerve-mediated contraction in guinea-pig airways. Br J Pharmacol 99: 473-476, 1990.
9. Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z, Toretsky JA. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res 65: 1719-1728, 2005.
10. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267: 10935-10938, 1992.
11. Lee EW, Grant DS, Movafagh S, Zukowska Z. Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides 24: 99-106, 2003.
12. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111: 1853-1862, 2003.
13. Li L, Lee EW, Ji H, Zukowska Z. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery. Arterioscler Thromb Vasc Biol 23: 1204-1210, 2003.
14. Liu JJ, Shi SG, Han QD. Evaluation of plasma neuropeptide Y levels in patients with congestive heart failure. Zhonghua Nei Ke Za Zhi 33: 687-689, 1994.
15. Madsen BK, Husum D, Videbaek R, Stokholm KH, Saelsen L, Christensen NJ. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise. Scand J Clin Lab Invest 53: 569-576, 1993.
16. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 325: 618-624, 1991.
17. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 88: 136-145, 1993.
18. Michalkiewicz M, Michalkiewicz T, Kreulen DL, McDougall SJ. Increased blood pressure responses in neuropeptide Y transgenic rats. Am J Physiol Regul Integr Comp Physiol 281: R417-R426, 2001.
19. Millar BC, Schluter KD, Zhou XJ, McDermott BJ, Piper HM. Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. Am J Physiol Cell Physiol 266: C1271-C1277, 1994.
20. Oellerich WF, Malik KU. Neuropeptide Y modulates the vascular response to periarterial nerve stimulation primarily by a postjunctional action in the isolated perfused rat kidney. J Pharmacol Exp Ther 266: 1321-1329, 1993.
21. Pfister A, Waeber B, Nussberger J, Brunner HR. Neuropeptide Y normalizes renin secretion in adrenalectomized rats without changing blood pressure. Life Sci 39: 2161-2167, 1986.
22. Pons J, Kitlinska J, Ji H, Lee EW, Zukowska Z. Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol 81: 177-185, 2003.
23. Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R. Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem 270: 29038, 1995.
24. Rump LC, Riess M, Schwertfeger E, Michel MC, Bohmann C, Schollmeyer P. Prejunctional neuropeptide Y receptors in human kidney and atrium. J Cardiovasc Pharmacol 29: 656-661, 1997.
25. Shin LH, Dovgan PS, Nypaver TJ, Carretero OA, Beierwaltes WH. Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat. J Vasc Surg 32: 1015-1021, 2000.
26. Ullman B, Hulting J, Lundberg JM. Prognostic value of plasma neuropeptide-Y in coronary care unit patients with and without acute myocardial infarction. Eur Heart J 15: 454-461, 1994.
27. Ullman B, Jensen-Urstad M, Hulting J, Lundberg JM. Neuropeptide Y, noradrenaline and invasive hemodynamic data in mild to moderate chronic congestive heart failure. Clin Physiol 13: 409-418, 1993.
28. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, Rump LC. Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc Res 66: 345-352, 2005.
29. Winaver J, Hoffman A, Burnett JC Jr, Haramati A. Hormonal determinants of sodium excretion in rats with experimental high-output heart failure. Am J Physiol Regul Integr Comp Physiol 254: R776-R784, 1988.
30. Zelis R, Nussberger J, Clemson B, Waeber B, Grouzmann E, Brunner HR. Neuropeptide Y infusion decreases plasma renin activity in postmyocardial infarction rats. J Cardiovasc Pharmacol 24: 896-899, 1994.
31. Zhang W, Lundberg JM, Thoren P. The effect of a neuropeptide Y antagonist, BIBP 3226, on short-term arterial pressure control in conscious unrestrained rats with congestive heart failure. Life Sci 65: 1839-1844, 1999.
32. Zukowska-Grojec Z. Neuropeptide Y. A novel sympathetic stress hormone and more. Ann NY Acad Sci 771: 219-233, 1995.
33. Zukowska-Grojec Z. Neuropeptide Y: an adrenergic cotransmitter, vasoconstrictor, and a nerve-derived vascular growth factor. Adv Pharmacol 42: 125-128, 1998.
34. Zukowska-Grojec Z, Haass M, Bayorh MA. Neuropeptide Y and peptide YY mediate nonadrenergic vasoconstriction and modulate sympathetic responses in rats. Regul Pept 15: 99-110, 1986.
35. Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E, Grant DS. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 83: 187-195, 1998.
36. Zukowska-Grojec Z, Wahlestedt C. Origin and actions of neuropeptide Y in the cardiovascular system. In: The Biology of Neuropeptide Y and Related Peptides, edited by Colmers WF and Wahlestedt C. Totowa, NJ: Human, 1993, p. 315-388.